Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Herpesvirus 8, Human | 39 | 2024 | 254 | 10.290 |
Why?
|
Antigens, Viral | 37 | 2024 | 995 | 6.420 |
Why?
|
Sarcoma, Kaposi | 15 | 2024 | 375 | 3.950 |
Why?
|
Nuclear Proteins | 34 | 2024 | 5783 | 3.570 |
Why?
|
Virus Latency | 17 | 2024 | 360 | 3.280 |
Why?
|
Plasmids | 17 | 2020 | 2274 | 3.230 |
Why?
|
DNA, Viral | 25 | 2021 | 2199 | 2.420 |
Why?
|
Terminal Repeat Sequences | 13 | 2019 | 70 | 2.370 |
Why?
|
DNA Replication | 13 | 2019 | 1433 | 1.530 |
Why?
|
Gene Expression Regulation, Viral | 6 | 2024 | 435 | 1.340 |
Why?
|
Rhadinovirus | 7 | 2018 | 37 | 1.140 |
Why?
|
Virus Replication | 11 | 2024 | 2447 | 1.140 |
Why?
|
Chromosomes | 7 | 2019 | 578 | 0.990 |
Why?
|
Nucleosomes | 4 | 2014 | 494 | 0.790 |
Why?
|
Genome, Viral | 7 | 2020 | 670 | 0.740 |
Why?
|
Herpesviridae Infections | 6 | 2019 | 268 | 0.690 |
Why?
|
Herpesvirus 4, Human | 11 | 2016 | 1078 | 0.660 |
Why?
|
Mitosis | 8 | 2019 | 1173 | 0.660 |
Why?
|
Ganciclovir | 1 | 2019 | 257 | 0.630 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2021 | 308 | 0.630 |
Why?
|
Viral Matrix Proteins | 8 | 1999 | 192 | 0.600 |
Why?
|
Germinal Center | 2 | 2017 | 379 | 0.580 |
Why?
|
Chromosomes, Human | 4 | 2011 | 437 | 0.560 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2021 | 691 | 0.550 |
Why?
|
Opportunistic Infections | 1 | 2019 | 376 | 0.530 |
Why?
|
beta-Lactams | 2 | 2009 | 158 | 0.500 |
Why?
|
Cell Transformation, Viral | 9 | 2020 | 527 | 0.500 |
Why?
|
Replication Protein C | 1 | 2014 | 26 | 0.470 |
Why?
|
B-Lymphocytes | 12 | 2023 | 4778 | 0.460 |
Why?
|
Antiviral Agents | 2 | 2019 | 3050 | 0.460 |
Why?
|
Cytomegalovirus Infections | 1 | 2019 | 836 | 0.410 |
Why?
|
Host-Pathogen Interactions | 6 | 2021 | 1461 | 0.380 |
Why?
|
Gastrointestinal Diseases | 1 | 2019 | 1203 | 0.360 |
Why?
|
Viral Proteins | 7 | 2019 | 1797 | 0.350 |
Why?
|
Herpesvirus 6, Human | 1 | 2011 | 97 | 0.350 |
Why?
|
Protein Binding | 12 | 2021 | 9296 | 0.320 |
Why?
|
Tumor Virus Infections | 3 | 2020 | 440 | 0.320 |
Why?
|
Lymphoma, Primary Effusion | 2 | 2020 | 17 | 0.320 |
Why?
|
Virulence Factors | 1 | 2011 | 500 | 0.300 |
Why?
|
Cell Line, Tumor | 11 | 2021 | 17075 | 0.290 |
Why?
|
Cell Line | 14 | 2019 | 15543 | 0.270 |
Why?
|
Proliferating Cell Nuclear Antigen | 2 | 2019 | 284 | 0.260 |
Why?
|
Centromere | 1 | 2006 | 213 | 0.250 |
Why?
|
Histones | 5 | 2020 | 2584 | 0.240 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2019 | 2429 | 0.240 |
Why?
|
Anti-Bacterial Agents | 4 | 2009 | 7478 | 0.230 |
Why?
|
Crystallography, X-Ray | 3 | 2021 | 1947 | 0.230 |
Why?
|
Protein Conformation | 4 | 2021 | 3946 | 0.230 |
Why?
|
Intracellular Signaling Peptides and Proteins | 3 | 2021 | 2880 | 0.220 |
Why?
|
Gene Knockdown Techniques | 2 | 2021 | 1599 | 0.220 |
Why?
|
Antigens, Nuclear | 2 | 2019 | 182 | 0.210 |
Why?
|
Cell Transformation, Neoplastic | 4 | 2021 | 2844 | 0.200 |
Why?
|
Enhancer Elements, Genetic | 2 | 2020 | 1365 | 0.190 |
Why?
|
Proto-Oncogene Proteins c-myc | 3 | 2020 | 995 | 0.190 |
Why?
|
DNA | 2 | 2024 | 7202 | 0.190 |
Why?
|
S-Phase Kinase-Associated Proteins | 1 | 2021 | 84 | 0.190 |
Why?
|
Cell Nucleus | 4 | 2019 | 2867 | 0.190 |
Why?
|
Binding Sites | 8 | 2018 | 6001 | 0.180 |
Why?
|
DNA-Binding Proteins | 5 | 2018 | 9601 | 0.180 |
Why?
|
Electrophoretic Mobility Shift Assay | 2 | 2013 | 295 | 0.170 |
Why?
|
Humans | 60 | 2024 | 765968 | 0.170 |
Why?
|
Viral Load | 3 | 2019 | 3386 | 0.170 |
Why?
|
Molecular Sequence Data | 11 | 2013 | 17594 | 0.160 |
Why?
|
Biosensing Techniques | 2 | 2016 | 642 | 0.160 |
Why?
|
Bacterial Infections | 3 | 2009 | 1387 | 0.160 |
Why?
|
NF-kappa B | 6 | 1999 | 2485 | 0.160 |
Why?
|
Pulmonary Fibrosis | 1 | 2023 | 503 | 0.160 |
Why?
|
Lymphoma, B-Cell | 2 | 2016 | 943 | 0.150 |
Why?
|
Protein Folding | 3 | 2013 | 869 | 0.140 |
Why?
|
Adenosine Kinase | 1 | 2017 | 13 | 0.140 |
Why?
|
Purine Nucleosides | 1 | 2017 | 30 | 0.140 |
Why?
|
Tumor Cells, Cultured | 6 | 2013 | 6113 | 0.140 |
Why?
|
Cell Cycle Proteins | 4 | 2019 | 3430 | 0.140 |
Why?
|
Promoter Regions, Genetic | 3 | 2020 | 5786 | 0.140 |
Why?
|
Idiopathic Pulmonary Fibrosis | 1 | 2023 | 518 | 0.140 |
Why?
|
Virus Diseases | 1 | 2023 | 718 | 0.140 |
Why?
|
Mutation | 8 | 2015 | 30198 | 0.140 |
Why?
|
Recombination, Genetic | 5 | 2013 | 1525 | 0.130 |
Why?
|
Amino Acid Sequence | 8 | 2018 | 13400 | 0.130 |
Why?
|
Protein Structure, Tertiary | 6 | 2015 | 3750 | 0.130 |
Why?
|
Base Sequence | 7 | 2011 | 12403 | 0.130 |
Why?
|
Lymphoma | 3 | 2002 | 1897 | 0.130 |
Why?
|
HEK293 Cells | 3 | 2020 | 4260 | 0.130 |
Why?
|
DNA-Directed DNA Polymerase | 2 | 2019 | 482 | 0.120 |
Why?
|
Clarithromycin | 1 | 1995 | 87 | 0.120 |
Why?
|
Microscopy, Fluorescence | 2 | 2013 | 2627 | 0.120 |
Why?
|
Static Electricity | 1 | 2015 | 259 | 0.120 |
Why?
|
DNA Repair | 1 | 2024 | 2048 | 0.120 |
Why?
|
Electricity | 1 | 2015 | 174 | 0.120 |
Why?
|
Pulmonary Embolism | 2 | 2023 | 2598 | 0.120 |
Why?
|
Dimerization | 2 | 2006 | 880 | 0.110 |
Why?
|
Azithromycin | 1 | 1995 | 201 | 0.110 |
Why?
|
Monocytes | 1 | 2023 | 2595 | 0.110 |
Why?
|
Fluorescence Polarization | 1 | 2014 | 140 | 0.110 |
Why?
|
Gene Expression | 2 | 2024 | 7584 | 0.110 |
Why?
|
Chromatin | 3 | 2013 | 2980 | 0.110 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2015 | 216 | 0.110 |
Why?
|
Anti-Infective Agents, Local | 1 | 1995 | 245 | 0.100 |
Why?
|
Lymphoproliferative Disorders | 1 | 2016 | 526 | 0.100 |
Why?
|
Animals | 19 | 2021 | 168764 | 0.100 |
Why?
|
Gram-Negative Aerobic Bacteria | 1 | 1992 | 8 | 0.100 |
Why?
|
Proteins | 6 | 1999 | 5995 | 0.100 |
Why?
|
Half-Life | 1 | 2013 | 644 | 0.100 |
Why?
|
Gene Regulatory Networks | 1 | 2020 | 1748 | 0.100 |
Why?
|
Fever | 1 | 2019 | 1603 | 0.100 |
Why?
|
Amino Acid Substitution | 2 | 2007 | 1740 | 0.100 |
Why?
|
Glutathione Transferase | 1 | 2014 | 562 | 0.100 |
Why?
|
Chickens | 1 | 2014 | 842 | 0.100 |
Why?
|
Spectrometry, Fluorescence | 1 | 2014 | 697 | 0.090 |
Why?
|
Headache | 1 | 2019 | 1259 | 0.090 |
Why?
|
DNA Primers | 3 | 2013 | 2825 | 0.090 |
Why?
|
Lab-On-A-Chip Devices | 1 | 2015 | 426 | 0.090 |
Why?
|
Cell Survival | 3 | 2017 | 5747 | 0.090 |
Why?
|
Chromosome Segregation | 1 | 2011 | 229 | 0.090 |
Why?
|
Nanostructures | 1 | 2015 | 548 | 0.090 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2015 | 3807 | 0.090 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 1992 | 239 | 0.080 |
Why?
|
Cell Division | 4 | 2011 | 4475 | 0.080 |
Why?
|
Ubiquitin-Protein Ligases | 2 | 2016 | 1892 | 0.080 |
Why?
|
Proteomics | 1 | 2023 | 3910 | 0.080 |
Why?
|
Cell Culture Techniques | 1 | 2016 | 1652 | 0.080 |
Why?
|
Thallium Radioisotopes | 1 | 1989 | 135 | 0.080 |
Why?
|
Models, Molecular | 3 | 2015 | 5379 | 0.080 |
Why?
|
Mice | 10 | 2021 | 81819 | 0.080 |
Why?
|
Flow Cytometry | 3 | 2015 | 5881 | 0.080 |
Why?
|
TNF Receptor-Associated Factor 2 | 6 | 1999 | 56 | 0.080 |
Why?
|
HeLa Cells | 2 | 2014 | 3067 | 0.080 |
Why?
|
Drug Design | 1 | 2014 | 1042 | 0.080 |
Why?
|
Ubiquitination | 1 | 2013 | 996 | 0.080 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2021 | 8611 | 0.080 |
Why?
|
Genomic Instability | 1 | 2013 | 718 | 0.080 |
Why?
|
Macrophages | 1 | 2023 | 5772 | 0.080 |
Why?
|
Antigens | 1 | 2014 | 1438 | 0.070 |
Why?
|
High-Throughput Screening Assays | 1 | 2014 | 938 | 0.070 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2020 | 3655 | 0.070 |
Why?
|
Catheterization, Central Venous | 1 | 1992 | 539 | 0.070 |
Why?
|
COS Cells | 2 | 2007 | 1136 | 0.070 |
Why?
|
Genome, Human | 1 | 2020 | 4448 | 0.070 |
Why?
|
Mammalian orthoreovirus 3 | 1 | 1986 | 45 | 0.070 |
Why?
|
Immunocompromised Host | 1 | 1992 | 866 | 0.070 |
Why?
|
Hemagglutinins, Viral | 1 | 1986 | 66 | 0.070 |
Why?
|
Polymerase Chain Reaction | 3 | 2011 | 6069 | 0.070 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 4562 | 0.070 |
Why?
|
Alanine | 1 | 2009 | 612 | 0.060 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 1996 | 2900 | 0.060 |
Why?
|
Blotting, Western | 1 | 2013 | 5020 | 0.060 |
Why?
|
Reoviridae | 1 | 1986 | 162 | 0.060 |
Why?
|
Fluorescent Dyes | 1 | 2014 | 1930 | 0.060 |
Why?
|
MicroRNAs | 1 | 2021 | 3785 | 0.060 |
Why?
|
Chromosomes, Mammalian | 1 | 2006 | 147 | 0.060 |
Why?
|
Cell Proliferation | 2 | 2020 | 10429 | 0.060 |
Why?
|
Amoxicillin-Potassium Clavulanate Combination | 1 | 2004 | 32 | 0.060 |
Why?
|
Erythrocytes | 1 | 2014 | 2395 | 0.060 |
Why?
|
Immunoprecipitation | 1 | 2007 | 870 | 0.060 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2006 | 429 | 0.060 |
Why?
|
Genomics | 1 | 2020 | 5929 | 0.060 |
Why?
|
Lactams | 1 | 2004 | 159 | 0.050 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2007 | 1679 | 0.050 |
Why?
|
Cephalosporins | 1 | 2004 | 200 | 0.050 |
Why?
|
Genes, Viral | 2 | 1999 | 654 | 0.050 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2007 | 632 | 0.050 |
Why?
|
Lymphocyte Activation | 1 | 1993 | 5501 | 0.050 |
Why?
|
Base Composition | 1 | 2002 | 291 | 0.050 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2015 | 4405 | 0.050 |
Why?
|
Xenopus laevis | 1 | 2006 | 964 | 0.050 |
Why?
|
Exercise Test | 1 | 1989 | 2180 | 0.050 |
Why?
|
Lymphocytes | 2 | 1999 | 2599 | 0.050 |
Why?
|
Immunity, Cellular | 1 | 2007 | 1555 | 0.050 |
Why?
|
TNF Receptor-Associated Factor 3 | 5 | 1999 | 38 | 0.040 |
Why?
|
TNF Receptor-Associated Factor 1 | 5 | 1999 | 48 | 0.040 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 2002 | 780 | 0.040 |
Why?
|
Precipitin Tests | 1 | 2001 | 812 | 0.040 |
Why?
|
Aminoglycosides | 1 | 2000 | 161 | 0.040 |
Why?
|
Cosmids | 1 | 1999 | 105 | 0.040 |
Why?
|
Herpesvirus 2, Saimiriine | 1 | 1999 | 61 | 0.040 |
Why?
|
DNA, Complementary | 1 | 2002 | 1984 | 0.040 |
Why?
|
Interferon Regulatory Factors | 1 | 2020 | 271 | 0.040 |
Why?
|
Recombinant Fusion Proteins | 2 | 2006 | 3737 | 0.040 |
Why?
|
Child | 3 | 2023 | 80564 | 0.040 |
Why?
|
Interphase | 1 | 1999 | 226 | 0.040 |
Why?
|
Bacteria | 1 | 2009 | 2209 | 0.040 |
Why?
|
Nucleic Acid Conformation | 2 | 2015 | 901 | 0.040 |
Why?
|
RNA, Messenger | 1 | 2013 | 12768 | 0.040 |
Why?
|
Structure-Activity Relationship | 1 | 2004 | 3051 | 0.040 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2006 | 1608 | 0.040 |
Why?
|
RNA Splicing | 1 | 2002 | 903 | 0.040 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 1999 | 440 | 0.040 |
Why?
|
Virus Integration | 1 | 2020 | 304 | 0.040 |
Why?
|
Treatment Outcome | 3 | 2019 | 65188 | 0.040 |
Why?
|
HIV-1 | 1 | 2015 | 6944 | 0.040 |
Why?
|
Gene Knockout Techniques | 1 | 2020 | 798 | 0.040 |
Why?
|
Acetylation | 1 | 2020 | 1053 | 0.040 |
Why?
|
Oncogene Proteins, Viral | 1 | 1999 | 341 | 0.040 |
Why?
|
3T3 Cells | 1 | 2018 | 1081 | 0.030 |
Why?
|
Fibroblasts | 2 | 1999 | 4159 | 0.030 |
Why?
|
Phenotype | 2 | 2009 | 16721 | 0.030 |
Why?
|
Transfection | 3 | 1999 | 5743 | 0.030 |
Why?
|
Inhibitory Concentration 50 | 1 | 2017 | 461 | 0.030 |
Why?
|
Pyoderma | 1 | 1995 | 7 | 0.030 |
Why?
|
Peptides | 1 | 2007 | 4331 | 0.030 |
Why?
|
Mice, Nude | 1 | 2021 | 3618 | 0.030 |
Why?
|
Binding, Competitive | 1 | 1996 | 1140 | 0.030 |
Why?
|
Spleen | 2 | 2015 | 2296 | 0.030 |
Why?
|
Pulmonary Artery | 1 | 2023 | 1935 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 1999 | 1240 | 0.030 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 1997 | 591 | 0.030 |
Why?
|
Virus Activation | 1 | 2016 | 323 | 0.030 |
Why?
|
Coronary Disease | 1 | 1989 | 5912 | 0.030 |
Why?
|
Mutant Proteins | 1 | 2016 | 488 | 0.030 |
Why?
|
Limit of Detection | 1 | 2015 | 272 | 0.030 |
Why?
|
DNA, Recombinant | 1 | 1995 | 455 | 0.030 |
Why?
|
Osmolar Concentration | 1 | 2015 | 655 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2017 | 13648 | 0.030 |
Why?
|
Thermodynamics | 1 | 2015 | 580 | 0.030 |
Why?
|
Endonucleases | 1 | 2016 | 372 | 0.030 |
Why?
|
Cytoplasm | 2 | 1996 | 1500 | 0.030 |
Why?
|
Enzyme Activation | 1 | 1999 | 3586 | 0.030 |
Why?
|
Antigens, Ly | 1 | 2015 | 296 | 0.030 |
Why?
|
Wound Infection | 1 | 1995 | 244 | 0.030 |
Why?
|
Codon | 1 | 1995 | 595 | 0.030 |
Why?
|
Microscopy, Confocal | 1 | 1999 | 1966 | 0.030 |
Why?
|
Electrophoresis, Gel, Pulsed-Field | 1 | 2013 | 142 | 0.030 |
Why?
|
Blotting, Southern | 1 | 1993 | 772 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2017 | 1837 | 0.030 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 2013 | 283 | 0.030 |
Why?
|
Bromodeoxyuridine | 1 | 2013 | 310 | 0.030 |
Why?
|
Drug Resistance, Microbial | 1 | 1995 | 833 | 0.020 |
Why?
|
Phylogeny | 1 | 2020 | 2832 | 0.020 |
Why?
|
Cell Line, Transformed | 1 | 1993 | 858 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2000 | 4850 | 0.020 |
Why?
|
Adult | 4 | 2019 | 223044 | 0.020 |
Why?
|
Mice, SCID | 1 | 2017 | 2630 | 0.020 |
Why?
|
F-Box Proteins | 1 | 2013 | 199 | 0.020 |
Why?
|
In Situ Nick-End Labeling | 1 | 2013 | 610 | 0.020 |
Why?
|
Reference Standards | 1 | 2015 | 1013 | 0.020 |
Why?
|
Protein Stability | 1 | 2013 | 577 | 0.020 |
Why?
|
Female | 6 | 2023 | 396112 | 0.020 |
Why?
|
Neoplasms | 1 | 2020 | 22340 | 0.020 |
Why?
|
Oligonucleotides, Antisense | 1 | 1993 | 462 | 0.020 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2015 | 2477 | 0.020 |
Why?
|
Protein Structure, Secondary | 1 | 1993 | 1210 | 0.020 |
Why?
|
HIV Infections | 2 | 2015 | 17533 | 0.020 |
Why?
|
Protein Multimerization | 1 | 2015 | 959 | 0.020 |
Why?
|
Immunoblotting | 1 | 1993 | 1644 | 0.020 |
Why?
|
Microfluidics | 1 | 2015 | 651 | 0.020 |
Why?
|
Open Reading Frames | 1 | 1993 | 820 | 0.020 |
Why?
|
Acne Vulgaris | 1 | 1995 | 352 | 0.020 |
Why?
|
Catheterization | 1 | 1995 | 1425 | 0.020 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2013 | 857 | 0.020 |
Why?
|
Up-Regulation | 1 | 2019 | 4137 | 0.020 |
Why?
|
Th1 Cells | 1 | 2015 | 1039 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2020 | 22332 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2007 | 10261 | 0.020 |
Why?
|
Environment | 1 | 2015 | 1114 | 0.020 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2015 | 617 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2002 | 7599 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2017 | 3608 | 0.020 |
Why?
|
Mice, Knockout | 2 | 2015 | 14448 | 0.020 |
Why?
|
Temperature | 1 | 2015 | 2226 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2016 | 4108 | 0.020 |
Why?
|
Computational Biology | 1 | 2020 | 3559 | 0.020 |
Why?
|
Recombinant Proteins | 2 | 1996 | 6493 | 0.020 |
Why?
|
Respiratory Tract Infections | 1 | 1995 | 1008 | 0.020 |
Why?
|
Equipment Design | 1 | 2015 | 3481 | 0.020 |
Why?
|
Interleukin-6 | 1 | 1997 | 3222 | 0.020 |
Why?
|
Mutation, Missense | 1 | 2016 | 2589 | 0.020 |
Why?
|
Callithrix | 2 | 1999 | 94 | 0.020 |
Why?
|
Reoviridae Infections | 1 | 1986 | 59 | 0.020 |
Why?
|
Interferon-gamma | 1 | 2015 | 3160 | 0.020 |
Why?
|
Point-of-Care Systems | 1 | 2015 | 1217 | 0.020 |
Why?
|
Cardiomegaly | 1 | 1989 | 589 | 0.020 |
Why?
|
Epitopes | 2 | 2007 | 2523 | 0.020 |
Why?
|
Genotype | 1 | 2020 | 13024 | 0.020 |
Why?
|
Incidence | 1 | 2023 | 21480 | 0.020 |
Why?
|
Macromolecular Substances | 1 | 2007 | 1430 | 0.010 |
Why?
|
Radionuclide Imaging | 1 | 1989 | 1978 | 0.010 |
Why?
|
Surface Properties | 1 | 2007 | 1151 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2020 | 14652 | 0.010 |
Why?
|
Heart Transplantation | 1 | 1998 | 3310 | 0.010 |
Why?
|
Lung | 1 | 2023 | 10033 | 0.010 |
Why?
|
Neutralization Tests | 1 | 1986 | 735 | 0.010 |
Why?
|
Cell Membrane | 1 | 1993 | 3634 | 0.010 |
Why?
|
Cells, Cultured | 1 | 1999 | 18973 | 0.010 |
Why?
|
Burns | 1 | 1995 | 1903 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2015 | 4348 | 0.010 |
Why?
|
Hospitalization | 1 | 2023 | 10808 | 0.010 |
Why?
|
Transcription Factors | 2 | 2016 | 12131 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2015 | 9550 | 0.010 |
Why?
|
Immunophenotyping | 1 | 2007 | 1866 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2017 | 5337 | 0.010 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2015 | 3111 | 0.010 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2015 | 4642 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2020 | 16047 | 0.010 |
Why?
|
Immunologic Memory | 1 | 2007 | 1375 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2013 | 4913 | 0.010 |
Why?
|
Brain | 1 | 1986 | 27171 | 0.010 |
Why?
|
Aotidae | 1 | 1999 | 57 | 0.010 |
Why?
|
Apoptosis | 1 | 2015 | 9514 | 0.010 |
Why?
|
Genome | 1 | 2006 | 1753 | 0.010 |
Why?
|
Infant | 1 | 2000 | 36386 | 0.010 |
Why?
|
Male | 5 | 2019 | 363698 | 0.010 |
Why?
|
HIV Seronegativity | 1 | 1998 | 209 | 0.010 |
Why?
|
Pleural Effusion, Malignant | 1 | 1998 | 109 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2015 | 11641 | 0.010 |
Why?
|
Intestines | 1 | 1986 | 1906 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2015 | 20124 | 0.010 |
Why?
|
Heart Ventricles | 1 | 1989 | 3832 | 0.010 |
Why?
|
United States | 1 | 2004 | 72903 | 0.010 |
Why?
|
Mutagenesis | 1 | 1999 | 1228 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2023 | 81514 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 1989 | 12976 | 0.010 |
Why?
|
Epithelium | 1 | 1997 | 1599 | 0.010 |
Why?
|
Sequence Deletion | 1 | 1997 | 1495 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 1996 | 2745 | 0.010 |
Why?
|
Transcriptional Activation | 1 | 1996 | 1744 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 1996 | 2086 | 0.010 |
Why?
|
Child, Preschool | 1 | 1992 | 42500 | 0.000 |
Why?
|
Kinetics | 1 | 1996 | 6274 | 0.000 |
Why?
|
Urinary Bladder Neoplasms | 1 | 1997 | 2176 | 0.000 |
Why?
|
Time Factors | 1 | 1986 | 40065 | 0.000 |
Why?
|
Hematopoietic Stem Cells | 1 | 1997 | 3401 | 0.000 |
Why?
|
Rats | 1 | 1999 | 23707 | 0.000 |
Why?
|
Ovarian Neoplasms | 1 | 1997 | 4900 | 0.000 |
Why?
|
Gene Expression Regulation | 1 | 1996 | 11888 | 0.000 |
Why?
|
Aged | 1 | 1989 | 171117 | 0.000 |
Why?
|
Middle Aged | 1 | 1998 | 223009 | 0.000 |
Why?
|